Cargando…

High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS

OBJECTIVE: Thyroid cancer is the most common primary malignant disorder of the thyroid. We aimed to illustrate the modified TI-RADS report system for differentiating malignant thyroid nodules from benign ones, and especially its role in the management of high risk nodules. METHODS: In this retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Menghui, Wei, Lijuan, Li, Fangxuan, Kan, Yanyan, Liang, Xiaofeng, Zhang, Huan, Liu, Juntian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810593/
https://www.ncbi.nlm.nih.gov/pubmed/33469366
http://dx.doi.org/10.2147/CMAR.S284370
_version_ 1783637332597932032
author Li, Menghui
Wei, Lijuan
Li, Fangxuan
Kan, Yanyan
Liang, Xiaofeng
Zhang, Huan
Liu, Juntian
author_facet Li, Menghui
Wei, Lijuan
Li, Fangxuan
Kan, Yanyan
Liang, Xiaofeng
Zhang, Huan
Liu, Juntian
author_sort Li, Menghui
collection PubMed
description OBJECTIVE: Thyroid cancer is the most common primary malignant disorder of the thyroid. We aimed to illustrate the modified TI-RADS report system for differentiating malignant thyroid nodules from benign ones, and especially its role in the management of high risk nodules. METHODS: In this retrospective study, 5,162 healthy individuals who underwent thyroid ultrasound according to modified TI-RADS from January 2014 to December 2014 were enrolled and followed up during the whole 5 years, and the medical data were investigated and reviewed. RESULTS: The total detection rate of thyroid nodules was 39.40%. The total detection rate of thyroid cancer was 0.66%. Most thyroid cancers were single-shot, located at unilateral, at early clinical stages, without lymph node metastases, and with low recurrence risk. All patients had thyroid papillary carcinoma, except one thyroid medullary carcinoma. Based on modified TI-RADS classification, at the end of 5 years follow-up, more changes of thyroid nodules grade status were observed in grades 4a and above. The higher the grade status, the more malignant advances were occurred. The modified TI-RADS report system played an instructional role in adding medical treatment choice and decision for clinicians. CONCLUSION: The modified TI-RADS report system plays an important role in thyroid benign and malignant nodule identification and management.
format Online
Article
Text
id pubmed-7810593
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78105932021-01-18 High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS Li, Menghui Wei, Lijuan Li, Fangxuan Kan, Yanyan Liang, Xiaofeng Zhang, Huan Liu, Juntian Cancer Manag Res Original Research OBJECTIVE: Thyroid cancer is the most common primary malignant disorder of the thyroid. We aimed to illustrate the modified TI-RADS report system for differentiating malignant thyroid nodules from benign ones, and especially its role in the management of high risk nodules. METHODS: In this retrospective study, 5,162 healthy individuals who underwent thyroid ultrasound according to modified TI-RADS from January 2014 to December 2014 were enrolled and followed up during the whole 5 years, and the medical data were investigated and reviewed. RESULTS: The total detection rate of thyroid nodules was 39.40%. The total detection rate of thyroid cancer was 0.66%. Most thyroid cancers were single-shot, located at unilateral, at early clinical stages, without lymph node metastases, and with low recurrence risk. All patients had thyroid papillary carcinoma, except one thyroid medullary carcinoma. Based on modified TI-RADS classification, at the end of 5 years follow-up, more changes of thyroid nodules grade status were observed in grades 4a and above. The higher the grade status, the more malignant advances were occurred. The modified TI-RADS report system played an instructional role in adding medical treatment choice and decision for clinicians. CONCLUSION: The modified TI-RADS report system plays an important role in thyroid benign and malignant nodule identification and management. Dove 2021-01-11 /pmc/articles/PMC7810593/ /pubmed/33469366 http://dx.doi.org/10.2147/CMAR.S284370 Text en © 2021 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Menghui
Wei, Lijuan
Li, Fangxuan
Kan, Yanyan
Liang, Xiaofeng
Zhang, Huan
Liu, Juntian
High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS
title High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS
title_full High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS
title_fullStr High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS
title_full_unstemmed High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS
title_short High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS
title_sort high risk thyroid nodule discrimination and management by modified ti-rads
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810593/
https://www.ncbi.nlm.nih.gov/pubmed/33469366
http://dx.doi.org/10.2147/CMAR.S284370
work_keys_str_mv AT limenghui highriskthyroidnodulediscriminationandmanagementbymodifiedtirads
AT weilijuan highriskthyroidnodulediscriminationandmanagementbymodifiedtirads
AT lifangxuan highriskthyroidnodulediscriminationandmanagementbymodifiedtirads
AT kanyanyan highriskthyroidnodulediscriminationandmanagementbymodifiedtirads
AT liangxiaofeng highriskthyroidnodulediscriminationandmanagementbymodifiedtirads
AT zhanghuan highriskthyroidnodulediscriminationandmanagementbymodifiedtirads
AT liujuntian highriskthyroidnodulediscriminationandmanagementbymodifiedtirads